- Home
- RDVT vs THW Comparison
RDVT vs THW Comparison
Compare RDVT & THW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | RDVT | THW |
|---|---|---|
| Founded | 2017 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Finance Companies |
| Sector | Technology | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 564.8M | 513.9M |
| IPO Year | 2017 | 2015 |
Fundamental Metrics
Financial Performance| Metric | RDVT | THW |
|---|---|---|
| Price | $43.42 | $12.17 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $62.00 | N/A |
| AVG Volume (30 Days) | 85.8K | ★ 142.6K |
| Earning Date | 06-09-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 82.00 | N/A |
| EPS | ★ 0.91 | N/A |
| Revenue | ★ $90,252,000.00 | N/A |
| Revenue This Year | $20.55 | N/A |
| Revenue Next Year | $14.27 | N/A |
| P/E Ratio | $49.60 | ★ N/A |
| Revenue Growth | ★ 20.03 | N/A |
| 52 Week Low | $32.23 | $9.80 |
| 52 Week High | $64.14 | $13.19 |
Technical Indicators
Market Signals| Indicator | RDVT | THW |
|---|---|---|
| Relative Strength Index (RSI) | 46.88 | 39.02 |
| Support Level | $39.89 | $11.80 |
| Resistance Level | $52.11 | $13.00 |
| Average True Range (ATR) | 2.29 | 0.20 |
| MACD | 0.57 | -0.06 |
| Stochastic Oscillator | 28.86 | 27.50 |
Price Performance
Historical ComparisonAbout RDVT Red Violet Inc.
Red Violet Inc is a software and services company. It specializes in data analysis, providing cloud-based, mission-critical information solutions to enterprises in a variety of industries. Through its CORE data fusion platform, it provides mission-critical information about individuals, businesses and assets.
About THW abrdn World Healthcare Fund Shares of Beneficial Interest
Tekla World Healthcare Fund is a diversified closed-end management investment company. Its investment objective is to seek current income and long-term capital appreciation. The Fund mainly invests in equity and debt securities of public and private U.S. and non-U.S. companies that the Fund's investment adviser believes have the potential for above-average growth. The company's investment portfolio includes holdings across various sub-sectors such as pharmaceuticals and biotechnology, healthcare providers and services, real estate investment trusts, medical devices and diagnostics, and other related areas.